3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Phase 2
1
Status
Completed
2
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Sarcoma
2
Lymphoid
1
Conditions
HIV Infections
2
Sarcoma, Kaposi
1
Lymphoma, AIDS-Related
1
Dendritic Cell Sarcoma, Interdigitating
1
Acquired Immunodeficiency Syndrome
1
Interventions
Doxorubicin
18
Vincristine
15
Zidovudine
11
Bleomycin
11
Cyclophosphamide
9
Etoposide
8
Interferon alpha-2
6
Prednisone
5
Cytarabine
5
tecogalan
4
sargramostim
4
Rituximab
4
Polymerase Chain Reaction
4
Liposomes
4
Filgrastim
4
Dexamethasone
4
Methotrexate
3
Leucovorin
3
Fluorouracil
3
interferon alfa-n1
2
Watchful Waiting
2
Vinblastine
2
Tumor Necrosis Factor-alpha
2
Thalidomide
2
Semaxinib
2
Ritonavir
2
Peripheral Blood Stem Cell Transplantation
2
Mitoxantrone
2
Light Coagulation
2
Isotretinoin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Completed
×
HIV Infections
×
Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
×
Clear all
NCT00444379
2014-08-20
ARKS
University of California, San Francisco
Phase 4
Completed
224 enrolled
NCT00799136
2013-09-12
CATCH
Ontario Clinical Oncology Group (OCOG)
Phase 2
Completed
6 enrolled